RxDoctor Payments Data

Tanya Solis, MD

Physical Medicine & Rehabilitation · Palestine, TXNPI 1497716393

Payments from drug & device makers

$1,692in general payments, 2019–2025

Across 65 payments — averaging $26.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$608
  • Abbott$248
  • SPR Therapeutics, Inc$245
  • Boston Scientific$125
  • Nevro Corp.$104
  • Tonix Medicines, Inc.$84
  • plus $277 from 7 others

What the payments were for

  • Food & beverage$1,692100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)32$608
Abbott14$248
SPR Therapeutics, Inc3$245
Boston Scientific5$125
Nevro Corp.1$104
Tonix Medicines, Inc.1$84
Amgen1$72
Stimwave Technologies Incorporated2$65
Vertex2$47
Nalu Medical, Inc.1$37
Avanos Medical1$22
Bioventus LLC1$19
Pfizer1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,692 in reported general payments places this provider in the 80th percentile of 651 physical medicine & rehabilitation providers in Texas.

See all physical medicine & rehabilitation providers in Texas

Medicare billing

Part B allowed, 2024
$145,011
Medicare patients
312
Services billed
6,618

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,071$27,575
Fentanyl91$19,364
OxycontinOxycodone Hcl25$16,671
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen324$12,679
NucyntaTapentadol Hcl13$9,156
Nucynta ErTapentadol Hcl12$7,054
Pregabalin166$4,495
Gabapentin221$2,741
Morphine Sulfate ErMorphine Sulfate56$2,435
Acetaminophen-CodeineAcetaminophen With Codeine77$2,309
Methocarbamol120$1,287
Oxycodone Hcl60$1,191
Methadone Hcl59$1,012
Tramadol Hcl ErTramadol Hcl22$964
Celecoxib55$863

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Palestine

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →